Literature DB >> 19587066

The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's disease.

Timothy J O'Brien1, Virginia Wadley, Anthony P Nicholas, Natividad P Stover, Ray Watts, H Randall Griffith.   

Abstract

Deficits in learning, memory, and executive functions are common cognitive sequelae of Parkinson's disease with dementia (PDD) and Alzheimer's disease (AD); however, the pattern of deficits within these populations is distinct. Hierarchical regression was used to investigate the contribution of two measures with executive function properties (Verbal Fluency and CLOX) on list-learning performance (CVLT-II total words learned) in a sample of 25 PDD patients and 25 matched AD patients. Executive measures were predictive of list learning in the PDD group after the contribution of overall cognition and contextual verbal learning was accounted for, whereas in the AD group the addition of executive measures did not add to prediction of variance in CVLT-II learning. These findings suggest that deficits in executive functions play a vital role in learning impairments in patients with PDD; however, for AD patients, learning difficulties appear relatively independent of executive dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19587066      PMCID: PMC2765349          DOI: 10.1093/arclin/acp029

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  31 in total

1.  Differential impact of executive dysfunction on verbal list learning and story recall.

Authors:  G Tremont; S Halpert; D J Javorsky; R A Stern
Journal:  Clin Neuropsychol       Date:  2000-08       Impact factor: 3.535

2.  Attentional control in Alzheimer's disease.

Authors:  A D Baddeley; H A Baddeley; R S Bucks; G K Wilcock
Journal:  Brain       Date:  2001-08       Impact factor: 13.501

3.  Memory and executive function impairment predict dementia in Parkinson's disease.

Authors:  Gilberto Levy; Diane M Jacobs; Ming-Xin Tang; Lucien J Côté; Elan D Louis; Brenda Alfaro; Helen Mejia; Yaakov Stern; Karen Marder
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

Review 4.  Functional neuroanatomy of the basal ganglia in Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Adv Neurol       Date:  2003

5.  Preclinical prediction of AD using neuropsychological tests.

Authors:  M S Albert; M B Moss; R Tanzi; K Jones
Journal:  J Int Neuropsychol Soc       Date:  2001-07       Impact factor: 2.892

6.  Memory impairment on free and cued selective reminding predicts dementia.

Authors:  E Grober; R B Lipton; C Hall; H Crystal
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

7.  The relationship between executive functioning and verbal and visual learning and memory.

Authors:  Kevin Duff; Mike R Schoenberg; James G Scott; Russell L Adams
Journal:  Arch Clin Neuropsychol       Date:  2005-01       Impact factor: 2.813

8.  California Verbal Learning Test: performance by patients with focal frontal and non-frontal lesions.

Authors:  M P Alexander; D T Stuss; N Fansabedian
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

9.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

Authors:  Dag Aarsland; Kjeld Andersen; Jan P Larsen; Anette Lolk; Per Kragh-Sørensen
Journal:  Arch Neurol       Date:  2003-03

10.  Working memory in mild Alzheimer's disease and early Parkinson's disease.

Authors:  Elizabeth A Kensinger; Deirdre K Shearer; Joseph J Locascio; John H Growdon; Suzanne Corkin
Journal:  Neuropsychology       Date:  2003-04       Impact factor: 3.295

View more
  5 in total

1.  Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Authors:  G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz
Journal:  Alzheimers Dement       Date:  2012-11-16       Impact factor: 21.566

2.  Partial correlation coefficient for a study with repeated measurements.

Authors:  Guogen Shan; Ece Bayram; Jessica Z K Caldwell; Justin B Miller; Jay J Shen; Shawn Gerstenberger
Journal:  Stat Biopharm Res       Date:  2020-07-20       Impact factor: 1.452

Review 3.  The overlap between vascular disease and Alzheimer's disease--lessons from pathology.

Authors:  Johannes Attems; Kurt A Jellinger
Journal:  BMC Med       Date:  2014-11-11       Impact factor: 8.775

4.  Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial.

Authors:  Elke Kalbe; Karsten Witt; Nele Schmidt; Inken Tödt; Daniela Berg; Christian Schlenstedt; Ann-Kristin Folkerts; Anja Ophey; Karina Dimenshteyn; Saskia Elben; Lars Wojtecki; Inga Liepelt-Scarfone; Claudia Schulte; Patricia Sulzer; Carsten Eggers
Journal:  J Neurol       Date:  2021-04-27       Impact factor: 6.682

5.  Cognitive characteristics in Chinese non-demented PD patients based on gender difference.

Authors:  Ke Yang; Bo Shen; Da-Ke Li; Ying Wang; Jue Zhao; Jian Zhao; Wen-Bo Yu; Zhen-Yang Liu; Yi-Lin Tang; Feng-Tao Liu; Huan Yu; Jian Wang; Qi-Hao Guo; Jian-Jun Wu
Journal:  Transl Neurodegener       Date:  2018-07-19       Impact factor: 8.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.